CenterBook Partners’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-15,360	Closed	-$675K	–	503
2024 Q2	$675K	Sell	15,360 -13,733	-47%	-$604K	0.04%	356
2024 Q1	$1.46M	Buy	29,093 +6,312	+28%	+$317K	0.1%	274
2023 Q4	$1.38M	Buy	22,781 +11,360	+99%	+$686K	0.17%	204
2023 Q3	$651K	Buy	+11,421	New	+$651K	0.08%	302